Argatroban Versus Lepirudin in Critically Ill Patients - A Randomized Double-Blind Trial.

Trial Profile

Argatroban Versus Lepirudin in Critically Ill Patients - A Randomized Double-Blind Trial.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2012

At a glance

  • Drugs Argatroban (Primary) ; Lepirudin
  • Indications Embolism and thrombosis; Heparin-induced thrombocytopenia and thrombosis syndrome; Various toxicities
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ALiCia
  • Most Recent Events

    • 20 Jun 2012 Actual patient number 70 added as reported by ClinicalTrials.gov.
    • 20 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 Jun 2012 Actual end date Mar 2012 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top